Chronic inflammation: is it the driver or is it paving the road for malignant transformation?
- PMID: 26124920
- PMCID: PMC4482242
- DOI: 10.18632/genesandcancer.64
Chronic inflammation: is it the driver or is it paving the road for malignant transformation?
Abstract
Chronic inflammation in well-defined mouse models such as Giα2 knock out mouse has been shown to trigger formation and expansion of hypoxic niches and also leads to up regulation of NFĸB, offering cells which have adapted their genetic machinery to hypoxia a unique survival advantage. These adapted cells have been shown to acquire stem cell-like capabilities as shown by up regulation of stem cell markers. Such long lived cells become permanent residents in sub mucosa and acquire a malignant phenotype from long-term exposure to noxious environmental agents due to a barrier defect secondary to down regulation of barrier proteins such as Zo1 and Occludin. Indeed mitotic spindle disorientation in such mice has been proposed as another contributory factor to malignant transformation. Sterilization of bowel lumen of these mice through different techniques has prevented malignant transformation in the presence of chronic inflammation. These facts stand strongly against chronic inflammation as a true driver of carcinogenesis but clearly support its role in facilitating the emergence of the neoplastic clone.
Keywords: Chronic inflammation; Free energy; JAK2V617F; bioenergetics; driver mutation; electric field and cancer; metabolomics; p53 Rb.
Conflict of interest statement
The authors declare that they have no conflict of interest whatsoever.
Figures

References
-
- Afrasiabi K., M.-S. J. Free energy measurement distinguishes normal from cancer cell, offering a new perspective for curing cancer. OnLine Journal of Biological Sciences. 2013;12:11–125.
-
- Zhou Y.H., Wu X., Tan F., Shi Y.X., Glass T., LIu T.J., Wathen K., Hess K.R., Gumin J., Lang F. PAX6 suppresses growth of human glioblastoma cells. J Neuro-Oncology. 2005;71:223–229. - PubMed
-
- Warburg O. On the origin of cancer cells. Science (New York, N.Y.) (1956);123:309–314. - PubMed
-
- Kumar S., Donti T.R., Agnihotri N., Mehta K. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways. International journal of cancer. Journal international du cancer. 2014;134:2798–2807. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous